Hybrids/Conjugates/Chimera Drugs-Antimicrobial Hybrids:Antibiotics, Antifungals, Antituberculars, Antimalarials

Antimicrobial hybrids are compounds that can inhibit, stop the growth of, or kill microorganisms, including bacteria, fungi, and parasites. Antibiotics, a subset of an-timicrobial agents, specifically target bacteria and include well-established classes such as β-lactams, macrolides, quinolones, and oxazolidinones. Other antimicrobial hybrids are designed for treating a wide range of diseases, including fungal infections, leish-maniasis, parasitic diseases (such as trypanosomiasis and malaria), leprosy, and tuber-culosis. Some hybrids are designed to treat a variety of diseases. This review highlights studies primarily published between 2000 and 2023, with a few from 2024, underscor-ing the dynamic and rapidly evolving nature of antimicrobial hybrid research.

Authors

Institutions

Publication Details

Journal
Current Medicinal Chemistry
Published
2025-08-04
DOI
https://doi.org/10.2174/0109298673362583250705102313
Primary Topic
Synthesis of β-Lactam Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hybrids/Conjugates/Chimera Drugs-Antimicrobial Hybrids:Antibiotics, Antifungals, Antituberculars, Antimalarials

Abraham Nudelman
Current Medicinal Chemistry
Synthesis of β-Lactam Compounds
article

Hybrids/Conjugates/Chimera Drugs-Antimicrobial Hybrids:Antibiotics, Antifungals, Antituberculars, Antimalarials

Abraham Nudelman
article en

Abstract

Antimicrobial hybrids are compounds that can inhibit, stop the growth of, or kill microorganisms, including bacteria, fungi, and parasites. Antibiotics, a subset of an-timicrobial agents, specifically target bacteria and include well-established classes such as β-lactams, macrolides, quinolones, and oxazolidinones. Other antimicrobial hybrids are designed for treating a wide range of diseases, including fungal infections, leish-maniasis, parasitic diseases (such as trypanosomiasis and malaria), leprosy, and tuber-culosis. Some hybrids are designed to treat a variety of diseases. This review highlights studies primarily published between 2000 and 2023, with a few from 2024, underscor-ing the dynamic and rapidly evolving nature of antimicrobial hybrid research.

Current Medicinal ChemistryVol. 32
Bar-Ilan University (IL)
Good health and well-being
Openalex Percentile: Top 85%
Synthesis of β-Lactam Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.